Smart Billing Solutions: Medical Billing Blog: Modifier and HCPCS …

The following new and deleted National Level II modifiers and HCPCS are effective for dates of service on/after January 1, 2014.

In compliance with the Health Insurance Portability and Accountability Act (HIPAA), CMS eliminated the 3-month grace period for discontinued codes in Change Request (CR) 3093 dated February 6, 2004. Effective for dates of services on/after January 1, 2010, there is no grace period for billing discontinued HCPCS codes.

NOTE: The inclusions of modifiers or codes in this article do not necessarily indicate coverage. New modifiers and HCPCS identified as Durable Medical Equipment (DME) are not included in this listing.

This taken from Noridian website, CMS update: https://med.noridianmedicare.com/web/jeb/article-detail/-/view/10525/modifier-and-hcpcs-changes-for-2014 Also follow this link to see deleted codes for 2014.

New Modifiers for 2014

New 2014 HCPCS

HCPCS Description
A4555 Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only
A9520 Technetium tc-99m, tilmanocept, diagnostic, up to 0.5 millicuries
A9575 Injection, gadoterate meglumine, 0.1 ml
A9599 Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose
C1841 Retinal prosthesis, includes all internal and external components
C5271 Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
C5272 Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
C5273 Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
C5274 Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
C5275 Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
C5276 Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
C5277 Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
C5278 Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
C9132 Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
C9133 Factor ix (antihemophilic factor, recombinant), rixibus, per i.u.
C9441 Injection, ferric carboxymaltose, 1 mg
C9497 Loxapine, inhalation powder, 10 mg
C9735 Anoscopy; with directed submucosal injection(s), any substance
C9737 Laparoscopy, surgical, esophageal sphincter augmentation with device (eg, magnetic band)
D0393 Treatment simulation using 3d image volume
D0394 Digital subtraction of two or more images or image volumes of the same modality
D0395 Fusion of two or more 3d image volumes of one or more modalities
D0601 Caries risk assessment and documentation, with a finding of low risk
D0602 Caries risk assessment and documentation, with a finding of moderate risk
D0603 Caries risk assessment and documentation, with a finding of high risk
D1999 Unspecified preventive procedure, by report
D2921 Reattachment of tooth fragment, incisal edge or cusp
D2941 Interim therapeutic restoration – primary dentition
D2949 Restorative foundation for an indirect restoration
D3355 Pulpal regeneration – initial visit
D3356 Pulpal regeneration – interim medication replacement
D3357 Pulpal regeneration – completion of treatment
D3427 Periradicular surgery without apicoectomy
D3428 Bone graft in conjunction with periradicular surgery – per tooth, single site
D3429 Bone graft in conjunction with periradicular surgery – each additional contiguous tooth in the same surgical site
D3431 Biologic materials to aid in soft and osseous tissue regeneration in conjunction with periradicular surgery
D3432 Guided tissue regeneration, resorbable barrier, per site, in conjunction with periradicular surgery
D4921 Gingival irrigation – per quadrant
D5863 Overdenture – complete maxillary
D5864 Overdenture – partial maxillary
D5865 Overdenture – complete mandibular
D5866 Overdenture – partial mandibular
D5994 Peridontal medicament carrier with peripheral seal – laboratory processed
D6011 Second stage implant surgery
D6013 Surgical placement of mini implant
D6052 Semi-precision attachment abutment
D8694 Repair of fixed retainers, includes reattachment
D9985 Sales tax
G0461 Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
G0462 Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)
G0463 Hospital outpatient clinic visit for assessment and management of a patient
G9187 Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code
G9188 Beta-blocker therapy not prescribed, reason not given
G9189 Beta-blocker therapy prescribed or currently being taken
G9190 Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)
G9191 Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)
G9192 Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)
G9193 Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression
G9194 Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase
G9195 Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase
G9196 Documentation of medical reason(s) for not ordering first or second generation cephalosporin for antimicrobial prophylaxis
G9197 Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis
G9198 Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given
G9199 Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))
G9200 Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given
G9201 Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission
G9202 Patients with a positive hepatitis c antibody test
G9203 Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
G9204 Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
G9205 Patient starting antiviral treatmentfor hepatitis c during the measurement period
G9206 Patient starting antiviral treatment for hepatitis c during the measurement period
G9207 Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
G9208 Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
G9209 Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
G9210 Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for reasons documented by clinician (eg, patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
G9211 Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
G9212 Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
G9213 Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
G9214 Cd4+ cell count or cd4+ cell percentage results documented
G9215 Cd4+ cell count or percentage not documented as performed, reason not given
G9216 Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given
G9217 Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 00 cells/mm3, reason not given
G9218 Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given
G9219 Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient’s cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient’s cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)
G9220 Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient’s cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient’s cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)
G9221 Pneumocystis jiroveci pneumonia prophlaxis prescribed
G9222 Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3
G9223 Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%
G9224 Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)
G9225 Foot exam was not performed, reason not given
G9226 Foot examination performed (includes examination through visual inspection, sensory exam with monofilament, and pulse exam – report when all of the 3 components are completed)
G9227 Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan
G9228 Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)
G9229 Chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)
G9230 Chlamydia, gonorrhea, and syphilis not screened, reason not given
G9231 Documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy
G9232 Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason
G9233 All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient
G9234 I intend to report the total knee replacement measures group
G9235 All quality actions for the applicable measures in the general surgery measures group have been performed for this patient
G9236 All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient
G9237 I intend to report the general surgery measures group
G9238 I intend to report the optimizing patient exposure to ionizing radiation measures group
G9239 Documentation of reasons for patient initiaiting maintenance hemodialysis with a catheter as the mode of vascular access (eg, patient has a maturing avf/avg, time-limited trial of hemodialysis, patients undergoing palliative dialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)
G9240 Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated
G9241 Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated
G9242 Documentation of viral load equal to or greater than 200 copies/ml
G9243 Documentation of viral load less than 200 copies/ml
G9244 Antiretroviral thereapy not prescribed
G9245 Antiretroviral therapy prescribed
G9246 Patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
G9247 Patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
G9248 Patient did not have a medical visit in the last 6 months
G9249 Patient had a medical visit in the last 6 months
G9250 Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment
G9251 Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment
G9252 Adenoma(s) or other neoplasm detected during screening colonoscopy
G9253 Adenoma(s) or other neoplasm not detected during screening colonoscopy
G9254 Documentation of patient discharged to home later than post-operative day 2 following cas
G9255 Documentation of patient discharged to home no later than post operative day 2 following cas
G9256 Documentation of patient death following cas
G9257 Documentation of patient stroke following cas
G9258 Documentation of patient stroke following cea
G9259 Documentation of patient survival and absence of stroke following cas
G9260 Documentation of patient death following cea
G9261 Documentation of patient survival and absence of stroke following cea
G9262 Documentation of patient death in the hospital following endovascular aaa repair
G9263 Documentation of patient survival in the hospital following endovascular aaa repair
G9264 Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (eg, patient is undergoing palliative dialysis with a catheter, patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant, other medical reasons, patient declined avf/avg, other patient reasons)
G9265 Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access
G9266 Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access
G9267 Documentation of patient with one or more complications or mortality within 30 days
G9268 Documentation of patient with one or more complications within 90 days
G9269 Documentation of patient without one or more complications and without mortality within 30 days
G9270 Documentation of patient without one or more complications within 90 days
G9271 Ldl value < 100
G9272 Ldl value >= 100
G9273 Blood pressure has a systolic value of < 140 and a diastolic value of < 90
G9274 Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90
G9275 Documentation that patient is a current non-tobacco user
G9276 Documentation that patient is a current tobacco user
G9277 Documentation that the patient is on daily aspirin or has documentation of a valid contraindication to aspirin automatic contraindications include anti-coagulant use, allergy, and history of gastrointestinal bleed; additionally, any reason documented by the physician as a reason for not taking daily aspirin is acceptable (examples include non-steroidal anti-inflammatory agents, risk for drug interaction, or uncontrolled hypertension defined as > 180 systolic or > 110 diastolic)
G9278 Documentation that the patient is not on daily aspirin regimen
G9279 Pneumococcal screening performed and documentation of vaccination received prior to discharge
G9280 Pneumococcal vaccination not administered prior to discharge, reason not specified
G9281 Screening performed and documentation that vaccination not indicated/patient refusal
G9282 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)
G9283 Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9284 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9285 Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer
G9286 Documentation of antibiotic regimen prescribed within 7 days of diagnosis or within 10 days after onset of symptoms
G9287 No antibiotic regimen prescribed within 7 days of diagnosis or within 10 days after onset of symptoms
G9288 Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons )
G9289 Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9290 Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9291 Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer  or classified as nsclc-nos
G9292 Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
G9293 Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9294 Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
G9295 Specimen site other than anatomic cutaneous location
G9296 Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy prior to the procedure
G9297 Shared decision-making including discussion of conservative (non-surgical) therapy prior to the procedure not documented, reason not given
G9298 Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including history of dvt, pe, mi, arrhythmia and stroke
G9299 Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including history of dvt, pe, mi, arrhythmia and stroke, reason not given
G9300 Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)
G9301 Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet
G9302 Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given
G9303 Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of the prosthetic implant, reason not given
G9304 Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of the prosthetic implant
G9305 Intervention for presence of leak of endoluminal contents through an anastomosis not required
G9306 Intervention for presence of leak of endoluminal contents through an anastomosis required
G9307 No return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure
G9308 Unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure
G9309 No unplanned hospital readmission within 30 days of principal procedure
G9310 Unplanned hospital readmission within 30 days of principal procedure
G9311 No surgical site infection
G9312 Surgical site infection
G9313 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason (eg, cystic fibrosis, immotile cilia disorders, ciliary dyskinesia, immune deficiency, prior history of sinus surgery within the past 12 months, and anatomic abnormalities, such as deviated nasal septum, resistant organisms, allergy to medication, recurrent sinusitis, chronic sinusitis, or other reasons)
G9314 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given
G9315 Documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis
G9316 Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family
G9317 Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed
G9318 Imaging study named according to standardized nomenclature
G9319 Imaging study not named according to standardized nomenclature, reason not given
G9320 Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9321 Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study
G9322 Count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given
G9323 Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9324 All necessary data elements not included, reason not given
G9325 Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9326 Ct studies performed not reported to a radiation dose index registry, reason not given
G9327 Ct studies performed reported to a radiation dose index registry with all necessary data elements
G9328 Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9329 Dicom format image data available to non-affiliated external entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given
G9340 Final report documented that dicom format image data available to non-affiliated external entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study
G9341 Search conducted for prior patient ct imaging studies completed at non-affiliated external entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed
G9342 Search conducted for prior patient imaging studies completed at non-affiliated external entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed not completed, reason not given
G9343 Search for prior patient completed dicom format images not completed due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)
G9344 Search for prior patient completed dicom format images not completed due to system reasons (ie, facility does not have archival abilities through a shared archival system)
G9345 Follow-up recommendations according to recommended guidelines for incidentally detected pulmonary nodules (eg, follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors documented
G9346 Follow-up recommendations according to recommended guidelines for incidentally detected pulmonary nodules not documented due to medical reasons (eg, patients with known malignant disease, patients with unexplained fever, ct studied performed for radiation treatment planning or image-guided radiation treatment delivery)
G9347 Follow-up recommendations according to recommended guidelines for incidentally detected pulmonary nodules not documented, reason not given
G9348 Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons (eg, persons with sinusitis symptoms lasting at least 7 to 10 days, antibiotic resistance, immunocompromised, recurrent sinusitis, acute frontal sinusitis, acute sphenoid sinusitis, periorbital cellulitis, or other medical)
G9349 Documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis
G9350 Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis
G9351 More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis
G9352 More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given
G9353 More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)
G9354 More than one ct scan of the paranasal sinuses not ordered within 90 days after the date of diagnosis
G9355 Elective delivery or early induction not performed
G9356 Elective delivery or early induction performed
G9357 Post-partum screenings, evaluations and education performed
G9358 Post-partum screenings, evaluations and education not performed
G9359 Documentation of negative or managed positive tb screen with further evidence that tb is not active
G9360 No documentation of negative or managed positive tb screen
J0401 Injection, aripiprazole, extended release, 1 mg
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1442 Injection, filgrastim (g-csf), 1 microgram
J1446 Injection, tbo-filgrastim, 5 micrograms
J1556 Injection, immune globulin (bivigam), 500 mg
J1602 Injection, golimumab, 1 mg, for intravenous use
J3060 Injection, taliglucerace alfa, 10 units
J3489 Injection, zoledronic acid, 1 mg
J7301 Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
J9047 Injection, carfilzomib, 1 mg
J9262 Injection, omacetaxine mepesuccinate, 0.01 mg
J9306 Injection, pertuzumab, 1 mg
J9354 Injection, ado-trastuzumab emtansine, 1 mg
J9371 Injection, vincristine sulfate liposome, 1 mg
J9400 Injection, ziv-aflibercept, 1 mg
L8679 Implantable neurostimulator, pulse generator, any type
Q0507 Miscellaneous supply or accessory for use with an external ventricular assist device
Q0508 Miscellaneous supply or accessory for use with an implanted ventricular assist device
Q0509 Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
Q2028 Injection, sculptra, 0.5 mg
Q2050 Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10mg
Q2052 Services, supplies and accessories used in the home under the medicare intravenous immune globulin (ivig) demonstration
Q3027 Injection, interferon beta-1a, 1 mcg for intramuscular use
Q3028 Injection, interferon beta-1a, 1 mcg for subcutaneous use
Q4137 Amnioexcel or biodexcel, per square centimeter
Q4138 Biodfence dryflex, per square centimeter
Q4139 Amniomatrix or biodmatrix, injectable, 1 cc
Q4140 Biodfence, per square centimeter
Q4141 Alloskin ac, per square centimeter
Q4142 Xcm biologic tissue matrix, per square centimeter
Q4143 Repriza, per square centimeter
Q4145 Epifix, injectable, 1 mg
Q4146 Tensix, per square centimeter
Q4147 Architect extracellular matrix, per square centimeter
Q4148 Neox 1k, per square centimeter
Q4149 Excellagen, 0.1 cc
S9960 Ambulance service, conventional air services, nonemergency transport, one way (fixed wing)
S9961 Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)
T4544 Adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each

Source: Smart Billing Solutions: Medical Billing Blog: Modifier and HCPCS …